This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Abtlas Co., Ltd.. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: An Insight into the Innovations of Hyo Jung Choi
Introduction
Hyo Jung Choi is an accomplished inventor based in Gangwon-do, South Korea. With a notable portfolio comprising two patents, Choi is paving the way for advancements in protein-based technologies.
Latest Patents
Choi's inventions address significant needs in the field of biotechnology. His first patent, titled "Protein combination-based Fv library and preparation method therefor," details a revolutionary method for constructing an Fv library. This library enables the screening of desired antibodies without requiring a target antigen preparation. Moreover, it significantly reduces the number of protein purification processes, thereby cutting down costs and time compared to conventional DNA-based libraries.
His second patent, "Method for refining protein including self-cutting cassette and use thereof," introduces a self-cleaving fusion protein. This innovative protein includes a target protein, a specific peptide sequence, and a tag, which facilitates the refinement of target proteins. The method described outlines how to culture, dissolve, and purify transformed cells, ultimately enabling the preparation of therapeutic antibody-drug conjugates.
Career Highlights
Choi is currently associated with Abtlas Co., Ltd., a company known for its commitment to pioneering biotech solutions. His innovative contributions help in advancing the field and demonstrate a deep understanding of protein functionality.
Collaborations
Collaboration plays a vital role in Choi's work. He works alongside esteemed colleagues, including Byeong Doo Song and Jee Sun Yun. Their combined expertise allows for enriched research and development, driving forward innovations in biotechnology.
Conclusion
Hyo Jung Choi is an influential figure in the realm of biotechnology. His innovative patents not only highlight his inventive spirit but also show the potential impact of his work on future therapeutic advancements. The efforts of Choi and his collaborators at Abtlas Co., Ltd. are instrumental in shaping next-generation solutions in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile